Spots Global Cancer Trial Database for positron emission tomography

Every month we try and update this database with for positron emission tomography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer	NCT04750473	Anatomic Stage ... Invasive Breast... Metastatic Brea... Prognostic Stag...	Computed Tomogr... Fluciclovine F1... Gallium Ga 68 G... Positron Emissi...	18 Years -	Emory University
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy	NCT01153672	Male Breast Can... Recurrent Breas... Stage IV Breast...	vorinostat laboratory biom... biopsy F-18 16 alpha-f... positron emissi... anastrozole letrozole exemestane gene expression...	18 Years -	University of Washington
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer	NCT05701176	Advanced Stage ...	[18F]F-AraG PET...	18 Years -	Amsterdam UMC, location VUmc
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors	NCT01243333	Malignant Neopl...	[F-18]fluorodeo... [F-18]fluorothy... Positron Emissi... Water O-15	18 Years -	University of Utah
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery	NCT01537107	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu...	vismodegib sirolimus positron emissi... computed tomogr... pharmacological... laboratory biom... fludeoxyglucose...	18 Years -	Mayo Clinic
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)	NCT06210750	T Acute Lymphob... T Lymphoblastic...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Dexamethasone Doxorubicin Echocardiograph... Lumbar Puncture Mercaptopurine Methotrexate Multigated Acqu... Navitoclax Nelarabine Pegaspargase Positron Emissi... Thioguanine Venetoclax Vincristine X-Ray Imaging	18 Years - 60 Years	National Cancer Institute (NCI)
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI	NCT04493411	Multiple Myelom...	WBMRI Positron Emissi...	18 Years -	University of Texas Southwestern Medical Center
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer	NCT05452005	Lung Cancer Lung Cancer Met... Brain Metastase... Non Small Cell ...	[18F]-αvβ6-BP	18 Years -	University of California, Davis
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer	NCT05470699	Prostate Carcin...	Computed Tomogr... Fluorine F 18 P... Positron Emissi...	21 Years -	City of Hope Medical Center
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma	NCT00123786	Sarcoma	Positron Emissi...	15 Years -	AHS Cancer Control Alberta
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer	NCT03811015	Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag...	Biospecimen Col... Cisplatin Computed Tomogr... Echocardiograph... Fludeoxyglucose... Intensity-Modul... Nivolumab Patient Observa... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma	NCT05665725	Non-Hodgkin Lym...	Biospecimen Col... Computed Tomogr... Positron Emissi... Siltuximab	18 Years -	Ohio State University Comprehensive Cancer Center
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer	NCT02827877	HER2 Positive B... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Copper Cu 64-DO... Laboratory Biom... Pertuzumab Positron Emissi... Therapeutic Con... Trastuzumab	18 Years -	City of Hope Medical Center
Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma	NCT06242834	B-Cell Non-Hodg...	Biospecimen Col... Computed Tomogr... Echocardiograph... Pembrolizumab Positron Emissi... Tazemetostat	18 Years -	Northwestern University
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma	NCT05359211	Recurrent Diffu... Recurrent Diffu... Recurrent Grade... Recurrent Prima... Refractory Diff... Refractory Diff... Refractory Grad... Refractory Prim... Transformed Ind...	Cyclophosphamid... Fludarabine Lisocabtagene M... Polymer-conjuga... X-Ray Imaging Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Lumbar Puncture Computed Tomogr... Positron Emissi... Biospecimen Col... Biopsy	18 Years -	Fred Hutchinson Cancer Center
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) With Osimertinib for the Treatment of Patients With Oligoprogressive EGFR Positive Non-small Cell Lung Carcinoma	NCT06014827	Lung Non-Small ... Stage IV Lung C...	Biospecimen Col... Computed Tomogr... Osimertinib Positron Emissi... Stereotactic Bo... Survey Administ...	18 Years -	City of Hope Medical Center
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma	NCT05861050	Blastoid Varian... Mantle Cell Lym... Pleomorphic Var...	Biopsy Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Glofitamab Lenalidomide Obinutuzumab Positron Emissi... Venetoclax	18 Years - 80 Years	City of Hope Medical Center
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)	NCT06401330	Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney...	Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging	- 30 Years	Children's Oncology Group
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer	NCT03448458	Castration-Resi... Metastatic Pros... Stage IV Prosta...	CT (Computed To... Gallium Ga 68-D... Positron Emissi...	18 Years -	Emory University
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	NCT01939275	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IA Gastri... Stage IB Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	copper Cu 64-DO... positron emissi... laboratory biom... Computed Tomogr...	18 Years -	City of Hope Medical Center
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer	NCT02624518	Prostate Adenoc...	68Ga-RM2 Magnetic Resona... Positron Emissi...	18 Years -	Stanford University
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules	NCT02448225	Lung Carcinoma Solitary Pulmon... Cigarette Smoki...	Computed Tomogr... Computed Tomogr... fluorodeoxygluc... Fluorine F 18 L... Laboratory Biom... Positron Emissi... Positron Emissi...	40 Years - 80 Years	Vanderbilt-Ingram Cancer Center
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)	NCT06216249	Prostate Carcin... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E...	18 Years -	Jonsson Comprehensive Cancer Center
[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib	NCT02175095	Colorectal Canc...	Regorafenib	20 Years -	Asan Medical Center
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma	NCT00662506	Adult Giant Cel... Adult Glioblast... Adult Gliosarco...	Cediranib Malea... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Intensity-Modul... Laboratory Biom... Perfusion Magne... Positron Emissi... Temozolomide	18 Years -	National Cancer Institute (NCI)
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer	NCT05547386	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Mayo Clinic
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma	NCT06232044	Recurrent Multi... Refractory Mult...	Iberdomide Belantamab Mafo... Dexamethasone Echocardiograph... Computed Tomogr... Magnetic Resona... Positron Emissi... Bone Marrow Bio... Bone Marrow Asp... Biospecimen Col...	18 Years -	Alliance for Clinical Trials in Oncology
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer	NCT01507428	Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung...	18F-Fluoromison... Carboplatin Computed Tomogr... Computed Tomogr... External Beam R... Fludeoxyglucose... Image-Guided Ad... Laboratory Biom... Paclitaxel Positron Emissi... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma	NCT04965454	Hepatocellular ...	Fluorine-18 flu...	18 Years -	Queen's Medical Center
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma	NCT05801913	High Grade B-Ce... Intermediate Gr... Recurrent B-Cel... Refractory B-Ce...	Anti-CD19-CAR C... Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Leukapheresis Lymphodepletion... Magnetic Resona... Multi-peptide C... Positron Emissi... X-Ray Imaging	18 Years -	City of Hope Medical Center
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases	NCT04752267	Anatomic Stage ... Clinical Stage ... Glioma Malignant Brain... Metastatic Brea... Metastatic Colo... Metastatic Kidn... Metastatic Lung... Metastatic Mali... Metastatic Mela... Pathologic Stag... Prognostic Stag... Stage IV Colon ... Stage IV Lung C... Stage IV Renal ... Stage IVA Colon... Stage IVA Lung ... Stage IVB Colon... Stage IVB Lung ... Stage IVC Colon...	Computed Tomogr... 18F-FMAU Multiparametric... Positron Emissi...	18 Years -	University of Southern California
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma	NCT06386315	Indolent B-Cell... Recurrent Indol... Refractory Indo... Recurrent Indol... Refractory Indo...	Computed Tomogr... Endoscopic Proc... Involved-site R... Involved-site R... Positron Emissi... Questionnaire A...	18 Years -	Mayo Clinic
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer	NCT06084845	Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Oral Cavity Squ... Oropharyngeal S... Stage III Cutan... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Cutane... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha...	Biospecimen Col... Carboplatin Chest Radiograp... Cisplatin Computed Tomogr... Image Guided Ra... Intensity-Modul... Magnetic Resona... Positron Emissi... Xevinapant	18 Years -	Eastern Cooperative Oncology Group
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer	NCT00362973	Breast Cancer	laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose...	18 Years - 120 Years	University of Washington
Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy	NCT03611205	Oropharyngeal S... HPV Positive Or...	Computed Tomogr... Positron Emissi...	18 Years -	Ohio State University Comprehensive Cancer Center
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial	NCT05497804	ISS Stage III P... Plasma Cell Mye...	Bone Marrow Asp... Carfilzomib Computed Tomogr... Daratumumab Dexamethasone Lenalidomide Magnetic Resona... Positron Emissi...	18 Years - 80 Years	Mayo Clinic
Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease	NCT03868020	Metastatic Head... Metastatic Squa...	Computed Tomogr... Fluciclovine F1... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment	NCT00324467	Lymphoma, Non-H... Advanced Stage ...	Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan	18 Years -	British Columbia Cancer Agency
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial	NCT04402788	Extensive Stage...	Atezolizumab Biospecimen Col... Computed Tomogr... Magnetic Resona... Positron Emissi... Radiation Thera...	18 Years -	National Cancer Institute (NCI)
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules	NCT03824535	Cigarette Smoke... Current Smoker Former Smoker Multiple Pulmon... Pulmonary Nodul...	Computed Tomogr... Fludeoxyglucose... Fluorine F 18 L... Positron Emissi...	45 Years -	Stanford University
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer	NCT05130073	Anal Squamous C... Stage 0 Anal Ca... Stage I Anal Ca... Stage II Anal C... Stage IIA Anal ... Stage IIB Anal ... Stage III Anal ... Stage IIIA Anal... Stage IIIB Anal... Stage IIIC Anal...	Computed Tomogr... Electronic Heal... Follow-Up Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer	NCT02073968	Metastatic Mali... Recurrent Non-S... Stage IIA Non-S... Stage IIB Non-S... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-Sm...	Carboplatin Computed Tomogr... Intensity-Modul... Paclitaxel Positron Emissi... Proton Beam Rad...	18 Years -	Albert Einstein College of Medicine
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	NCT01939275	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IA Gastri... Stage IB Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	copper Cu 64-DO... positron emissi... laboratory biom... Computed Tomogr...	18 Years -	City of Hope Medical Center
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma	NCT04965454	Hepatocellular ...	Fluorine-18 flu...	18 Years -	Queen's Medical Center
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer	NCT05176223	Advanced Hepato... Stage III Hepat... Stage IV Hepato... Unresectable He...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Mayo Clinic
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer	NCT05130073	Anal Squamous C... Stage 0 Anal Ca... Stage I Anal Ca... Stage II Anal C... Stage IIA Anal ... Stage IIB Anal ... Stage III Anal ... Stage IIIA Anal... Stage IIIB Anal... Stage IIIC Anal...	Computed Tomogr... Electronic Heal... Follow-Up Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers	NCT04459273	Bladder Carcino... Cervical Carcin... Cholangiocarcin... Hematopoietic a... Hepatocellular ... Malignant Adren... Malignant Brain... Malignant Pleur... Malignant Skin ... Malignant Solid... Malignant Testi... Malignant Thymu... Neuroendocrine ... Thyroid Gland C... Urothelial Carc... Cancer of Unkno...	Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG	18 Years -	Jonsson Comprehensive Cancer Center
Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer	NCT00165568	Colorectal Canc... Neoplasm Metast...	Bevacizumab	18 Years -	Dana-Farber Cancer Institute
Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma	NCT06042725	Multiple Myelom...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Chest Radiograp... Computed Tomogr... Daratumumab Dexamethasone Lenalidomide Low Dose Comput... Magnetic Resona... Positron Emissi... Venetoclax X-Ray Imaging Questionnaire A...	18 Years -	Mayo Clinic
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer	NCT05172245	Clinical Stage ... Head and Neck C... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Maxillary Sinus... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage III Sinon... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Lip a... Stage IVA Oroph... Stage IVA Sinon... Stage IVB Hypop... Stage IVB Laryn... Stage IVB Lip a... Stage IVB Oroph... Stage IVB Sinon...	Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Ipatasertib Magnetic Resona... Positron Emissi... Radiation Thera...	18 Years -	National Cancer Institute (NCI)
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression	NCT04927663	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Solid Tumor, Ad... Solid Tumor Metastatic Cast...	Computed Tomogr... Magnetic Resona... Positron Emissi... 11C-YJH08 Optional Tumor ...	18 Years -	University of California, San Francisco
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial	NCT05775939	Lung Carcinoma Esophageal Carc...	Fludeoxyglucose... Positron Emissi... Computed Tomogr... Questionnaire A...	18 Years -	Thomas Jefferson University
An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer	NCT01266954	Solid Tumours	GSK2141795	18 Years - 85 Years	GlaxoSmithKline
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer	NCT06381154	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin	18 Years -	Mayo Clinic
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors	NCT04840589	Metastatic Mali... Recurrent Malig... Recurrent Plati... Refractory Ovar...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy	NCT00450567	Lung Cancer	computed tomogr... positron emissi... fludeoxyglucose...	18 Years -	Jonsson Comprehensive Cancer Center
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer	NCT00310219	Lung Cancer	computed tomogr... positron emissi...	18 Years -	Radiation Therapy Oncology Group
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies	NCT00880074	Malignant Neopl...	Fluorothymidine... Laboratory Biom... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma	NCT06420349	Advanced Cholan... Metastatic Chol... Refractory Chol... Stage III Hilar... Stage III Intra... Stage IV Hilar ... Stage IV Intrah...	Biospecimen Col... Computed Tomogr... Heat Shock Fact... Magnetic Resona... Positron Emissi... Ultrasound-Guid...	18 Years -	Mayo Clinic
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease	NCT03025256	Acral Lentigino... Central Nervous... Clinical Stage ... Leptomeningeal ... Melanocytoma Metastatic Lung... Metastatic Mela... Metastatic Muco... Metastatic Uvea... Stage IV Lung C...	Biospecimen Col... Computed Tomogr... Lumbar Puncture Magnetic Resona... Nivolumab Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer	NCT03448458	Castration-Resi... Metastatic Pros... Stage IV Prosta...	CT (Computed To... Gallium Ga 68-D... Positron Emissi...	18 Years -	Emory University
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery	NCT03515577	Recurrent Prost...	Computed Tomogr... Fluciclovine F1... Gallium Ga 68-l... Laboratory Biom... Positron Emissi...	19 Years -	Jonsson Comprehensive Cancer Center
PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma	NCT01502228	Renal Cell Carc...	150-Water 62Cu-ethylglyox... Positron Emissi... Sunitinib	18 Years -	Indiana University
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer	NCT02287636	Childhood Cance...	fludeoxyglucose... positron emissi... computed tomogr... positron emissi... magnetic resona...	- 17 Years	Case Comprehensive Cancer Center
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer	NCT04762888	Hepatocellular ...	Computed Tomogr... Gallium Ga 68 G... Magnetic Resona... Positron Emissi...	18 Years -	Mayo Clinic
Feasibility of FMISO in Brain Tumors	NCT03649880	Malignant Brain...	¹⁸F-Fluoromison... Computed Tomogr... Magnetic Resona... Positron Emissi... Oxygen Therapy	18 Years -	OHSU Knight Cancer Institute
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	NCT02408861	Advanced Malign... Anal Carcinoma HIV Infection Kaposi Sarcoma Lung Carcinoma Metastatic Mali... Recurrent Class... Refractory Clas... Unresectable So...	Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Ipilimumab Nivolumab Positron Emissi...	18 Years -	National Cancer Institute (NCI)
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules	NCT02448225	Lung Carcinoma Solitary Pulmon... Cigarette Smoki...	Computed Tomogr... Computed Tomogr... fluorodeoxygluc... Fluorine F 18 L... Laboratory Biom... Positron Emissi... Positron Emissi...	40 Years - 80 Years	Vanderbilt-Ingram Cancer Center
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study	NCT05781321	Glioblastoma	Accelerated Hyp... Computed Tomogr... Fluorodopa F 18 Magnetic Resona... Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... Temozolomide Biospecimen Col...	18 Years -	Mayo Clinic
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion	NCT04976257	Prostate Adenoc... Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Angiogram Catheterization Gallium Ga-labe... Positron Emissi...	18 Years - 80 Years	University of California, San Francisco
Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy	NCT05936229	Recurrent B Acu... Recurrent B-Cel... Refractory B Ac... Refractory B-Ce... Recurrent Mantl... Refractory Mant...	Interferon Beta... X-Ray Imaging Echocardiograph... Multigated Acqu... Computed Tomogr... Positron Emissi... Lumbar Puncture Bone Marrow Asp... Bone Marrow Bio... Biospecimen Col... Biopsy	18 Years -	Fred Hutchinson Cancer Center
FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia	NCT02392429	Acute Myeloid L...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Chemotherapy Computed Tomogr... Cytarabine Fluorothymidine... Laboratory Biom... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative	NCT04929041	Lung Adenocarci... Lung Adenosquam... Lung Non-Small ... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C...	Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi... Quality-of-Life... Stereotactic Bo...	18 Years -	National Cancer Institute (NCI)
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer	NCT02810873	Breast Carcinom...	Positron Emissi... Positron Emissi... Fludeoxyglucose... Copper Cu 64 TP...	18 Years -	Thomas Jefferson University
Pirtobrutinib With Rituximab for the Treatment of Newly Diagnosed Marginal Zone Lymphoma	NCT06390956	Marginal Zone L...	Biopsy Biospecimen Col... Computed Tomogr... Pirtobrutinib Positron Emissi... Rituximab	18 Years -	Ohio State University Comprehensive Cancer Center
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis	NCT06022939	AL Amyloidosis	Autologous Hema... Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bortezomib Computed Tomogr... Cyclophosphamid... Daratumumab and... Dexamethasone Echocardiograph... Magnetic Resona... Melphalan Positron Emissi... Stem Cell Isola... Survey Administ...	18 Years -	SWOG Cancer Research Network

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: